Current Interventional Cardiology Reports
Overview
Current Interventional Cardiology Reports is a scientific journal, published by Current Science since 1999 in English. The journal's country of origin is United States and its primary focus area is cardiology & vascular diseases.
Details
Details
Abbr.
Curr Interv Cardiol Rep
Publisher
Current Science
Start
1999
End
2001
Frequency
Quarterly
p-ISSN
1523-3839
e-ISSN
1534-3103
Country
United States
Language
English
Specialty
Cardiology & Vascular Diseases
Recent Articles
1.
Goh T
Curr Interv Cardiol Rep
. 2001 Nov;
3(4):354-361.
PMID: 11696302
This report discusses the worldwide experience of transcatheter and intraoperative closure of ventricular septal defects (VSDs) using the Rashkind and Clamshell devices, including the author's personal experience and communications. This...
2.
Sideris E, Haddad J, Rao P
Curr Interv Cardiol Rep
. 2001 Nov;
3(4):349-353.
PMID: 11696301
Transcatheter ventricular septal defect (VSD) occlusion was performed in 55 patients using two disk devices (the buttoned device transvenously and the self-adjustable device transarterially) and wireless devices (transcatheter patch and...
3.
El-Omar M, Dangas G, Stone G
Curr Interv Cardiol Rep
. 2001 Nov;
3(4):336-345.
PMID: 11696300
Three intravenous glycoprotein IIb/IIIa inhibitors, abciximab, tirofiban, and eptifibatide, when administered intravenously just before percutaneous intervention, have been shown to reduce the composite 30-day occurrence of death, myocardial infarction, or...
4.
Wright R, Barsness G
Curr Interv Cardiol Rep
. 2001 Nov;
3(4):330-335.
PMID: 11696299
Diabetes mellitus is an increasing problem in the Western world and is associated with a more advanced state of coronary artery disease than that observed in non-diabetic patients. Diabetes mellitus...
5.
Cantor W, Ohman E
Curr Interv Cardiol Rep
. 2001 Nov;
3(4):321-329.
PMID: 11696298
In acute myocardial infarction, reperfusion therapy is needed to restore coronary flow and myocardial perfusion. Thrombolytic therapy is widely available and can be administered rapidly but does not achieve the...
6.
Dzavik V
Curr Interv Cardiol Rep
. 2001 Nov;
3(4):311-320.
PMID: 11696297
Since 1982, there have been many reports regarding percutaneous transluminal coronary angioplasty of totally occluded coronary arteries. Technical advances and operator experience have allowed us to achieve success in most...
7.
Togni M, Windecker S, Meier B
Curr Interv Cardiol Rep
. 2001 Nov;
3(4):306-310.
PMID: 11696296
Restenosis constitutes the major limitation to the effectiveness of percutaneous coronary intervention. The advent of stent placement has engendered an even more difficult-to-treat entity: in-stent restenosis. Restenosis should be treated...
8.
El-Omar M, Dangas G, Iakovou I, Mehran R
Curr Interv Cardiol Rep
. 2001 Nov;
3(4):296-305.
PMID: 11696295
Although stents mitigate the risk of restenosis, in-stent restenosis (ISR) is still an important clinical problem. ISR usually occurs within the first 3 to 6 months after stenting, with little...
9.
Pratsos A, Fischman D, Savage M
Curr Interv Cardiol Rep
. 2001 Nov;
3(4):287-295.
PMID: 11696294
The growing population of patients with aged saphenous vein grafts has become a clinical challenge of increasing magnitude. Efforts to treat these patients with transcatheter interventions have been limited by...
10.
Bauters C, Lamblin N, Amouyel P
Curr Interv Cardiol Rep
. 2001 Nov;
3(4):281-286.
PMID: 11696293
This paper discusses the role of genetic factors as predictors of acute closure and restenosis after coronary angioplasty. Two examples are discussed: 1) The phospholipase A(2) (PlA(2)) polymorphism of the...